Vaxart Plans to Push COVID-19 Vaccine Candidate into the Clinic
Excerpt From the Article:
Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic.
Sean Tucker, Vaxart’s chief scientific officer, said the early preclinical results for the COVID-19 vaccines are in line with the company’s universal flu vaccine candidate, which is now in Phase II testing.
Click the button below to read the entire article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?